The Medway CCG is looking to appoint a provider that can deliver a high quality, effective, accessible, timely, responsive, non-discriminatory cost effective community based anticoagulation therapy service that will address the health needs of the population at flexible sites, through a flexible model of delivery that significantly contributes both to improving the well-being of the population and to reducing inequalities.

The service shall:

Deliver services which are more accessible and convenient for patients, i.e. close to patient's homes, timely and easily accessible. Ensure efficient, timely and prompt communication mechanisms between the anticoagulation service and GP's; Deliver clear and appropriate treatment pathway(s) for patients, for use by referrers, and ensure patients move smoothly through the pathway by facilitating appropriate onward referral; Support the onward referral of patients into primary, secondary and tertiary services and where necessary provide electronic reports and treatment guidance. Inform referring clinicians of the need to urgently onward refer where appropriate. Deliver the right medication, right dose, right patients, right time and right route. Improved patient pathway and experience. To included but not exhaustive: Management of patient Self-management/self-monitoring Domiciliary Interoperability with acute hospitals and other community services e.g. stroke, AF. Interoperability with GPs, including recommendations on medication changes and for NOAC prescribing Management of patients receiving vitamin K antagonists at risk of under-coagulation, (result in thrombosis), and over-coagulation (result in haemorrhage) The service will comprise of a multi-disciplinary team which will have access to a suitable level of relevant clinical advice during clinic times.